Watch Ticker

Alnylam Pharmaceuticals, Inc.

Go to Alnylam Pharmaceuticals, Inc. Website

$147.89

(%)

Live

Previous Close

$147.89

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$18.7 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y

Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.

Related tickers: REGN, ALNY, NVS, RHHBY.

Read Full Article

Zacks Equity Research - Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Related tickers: ALNY.

Read Full Article

Trending Tickers

BTTX

XNAS

$0.01

(%)

OPRT

XNAS

$4.23

(%)

PALI

XNAS

$6.24

(%)

PRSO

XNAS

$1.42

(%)

ACRV

XNAS

$0.00

(%)